| 14.70 Data as of 4:00pm ET |  +0.47 / +3.30%Today’s Change | 10.26 Today|||52-Week Range 18.27 | -9.82% Year-to-Date |
| IVC July Options Begin Trading May 20 / TheStreet.com | This Metric Suggests You're Right to Own Invacare. May 15 / MotleyFool.com |
| Previous close | 14.23 |
| Today’s open | 14.13 |
| Day’s range | 13.86 - 14.76 |
| Volume | 265,471 |
| Average volume (3 months) | 266,037 |
| Market cap | $455.4M |
| Dividend yield | 0.34% |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -168.97% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | -19.06% |
| P/E ratio | NM |
| Price/Sales | 0.35 |
| Price/Book | 0.73 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARAYAccuray Inc | -0.01 | -0.19% |
| CYNOCynosure Inc | +1.06 | +4.42% |
| TEARTearLab Corp | +0.73 | +7.64% |
| NVDQNovadaq Technologies... | +0.07 | +0.52% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $1.8M |
| Net profit margin | -0.57% |
Sector Health Technology |
Industry Medical Specialties |
Chairman Aaron Malachi Mixon, III, MBA |
President, Chief Executive Officer & Director Gerald B. Blouch, MBA |
Corporate headquarters Elyria, Ohio |
.
